NASDAQ:EDIT

1.44
0.45 (23.81%) 1d
0
DON'T BUY
Editas Medicine
Gene editing is great, but you can't buy growth stocks that have no hope of making money, not in this market.
biotechnology
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Editas Medicine(EDIT-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Editas Medicine is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Editas Medicine(EDIT-Q) Frequently Asked Questions

What is Editas Medicine stock symbol?

Editas Medicine is a American stock, trading under the symbol EDIT-Q on the NASDAQ (EDIT). It is usually referred to as NASDAQ:EDIT or EDIT-Q

Is Editas Medicine a buy or a sell?

In the last year, there was no coverage of Editas Medicine published on Stockchase.

Is Editas Medicine a good investment or a top pick?

Editas Medicine was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Editas Medicine.

Why is Editas Medicine stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Editas Medicine worth watching?

In the last year, there was no coverage of Editas Medicine published on Stockchase.

What is Editas Medicine stock price?

On 2024-12-13, Editas Medicine (EDIT-Q) stock closed at a price of $1.44.